Baxter Research and Development Expenses 2012-2026 | BAX
Baxter annual/quarterly research and development expenses history and growth rate from 2012 to 2026. Research and development expenses can be defined as an expense arising from studies and product development processes.
- Baxter research and development expenses for the quarter ending June 30, 2026 were $129M, a 3.73% decline year-over-year.
- Baxter research and development expenses for the twelve months ending June 30, 2026 were $512M, a 16.61% decline year-over-year.
- Baxter annual research and development expenses for 2025 were $0.518B, a 12.2% decline from 2024.
- Baxter annual research and development expenses for 2024 were $0.59B, a 13.9% increase from 2023.
- Baxter annual research and development expenses for 2023 were $0.518B, a 15.11% increase from 2022.
|
Baxter Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2025 | $518 |
| 2024 | $590 |
| 2023 | $518 |
| 2022 | $450 |
| 2021 | $531 |
| 2020 | $521 |
| 2019 | $595 |
| 2018 | $654 |
| 2017 | $615 |
| 2016 | $646 |
| 2015 | $603 |
| 2014 | $610 |
| 2013 | $582 |
| 2012 | $1,081 |
| 2011 | $946 |
|
Baxter Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2026-06-30 | $129 |
| 2026-03-31 | $139 |
| 2025-12-31 | $126 |
| 2025-09-30 | $118 |
| 2025-06-30 | $134 |
| 2025-03-31 | $140 |
| 2024-12-31 | $211 |
| 2024-09-30 | $129 |
| 2024-06-30 | $130 |
| 2024-03-31 | $120 |
| 2023-12-31 | $56 |
| 2023-09-30 | $133 |
| 2023-06-30 | $165 |
| 2023-03-31 | $164 |
| 2022-12-31 | $1 |
| 2022-09-30 | $151 |
| 2022-06-30 | $148 |
| 2022-03-31 | $150 |
| 2021-12-31 | $135 |
| 2021-09-30 | $129 |
| 2021-06-30 | $139 |
| 2021-03-31 | $128 |
| 2020-12-31 | $135 |
| 2020-09-30 | $123 |
| 2020-06-30 | $117 |
| 2020-03-31 | $146 |
| 2019-12-31 | $156 |
| 2019-09-30 | $144 |
| 2019-06-30 | $166 |
| 2019-03-31 | $129 |
| 2018-12-31 | $174 |
| 2018-09-30 | $166 |
| 2018-06-30 | $174 |
| 2018-03-31 | $140 |
| 2017-12-31 | $183 |
| 2017-09-30 | $150 |
| 2017-06-30 | $155 |
| 2017-03-31 | $127 |
| 2016-12-31 | $156 |
| 2016-09-30 | $159 |
| 2016-06-30 | $195 |
| 2016-03-31 | $136 |
| 2015-12-31 | $161 |
| 2015-09-30 | $148 |
| 2015-06-30 | $151 |
| 2015-03-31 | $143 |
| 2014-12-31 | $156 |
| 2014-09-30 | $149 |
| 2014-06-30 | $322 |
| 2014-03-31 | $309 |
| 2013-12-31 | $396 |
| 2013-09-30 | $277 |
| 2013-06-30 | $273 |
| 2013-03-31 | $246 |
| 2012-12-31 | $216 |
| 2012-09-30 | $290 |
| 2012-06-30 | $306 |
| 2012-03-31 | $269 |
| 2011-12-31 | $254 |
| 2011-09-30 | $239 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $11.788B | $11.244B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $177.555B | 19.51 |
| Medtronic (MDT) | Ireland | $117.847B | 16.11 |
| Stryker (SYK) | United States | $105.529B | 19.72 |
| EssilorLuxottica (ESLOY) | France | $73.880B | 0.00 |
| Boston Scientific (BSX) | United States | $62.810B | 13.50 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.597B | 0.00 |
| Agilent Technologies (A) | United States | $44.113B | 25.82 |
| Medline (MDLN) | United States | $41.597B | 0.00 |
| ResMed (RMD) | United States | $32.455B | 20.14 |
| GE HealthCare Technologies (GEHC) | United States | $28.967B | 13.85 |
| Koninklijke Philips (PHG) | Netherlands | $24.258B | 12.92 |
| Terumo (TRUMY) | Japan | $20.887B | 19.94 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.189B | 11.24 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.573B | 0.00 |
| Demant (WILYY) | Denmark | $10.101B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.065B | 40.56 |
| Insulet (PODD) | United States | $9.751B | 23.95 |
| Sunny Optical Technology (SNPTF) | China | $9.508B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.563B | 20.19 |
| Raia Drogasil SA - (RADLY) | Brazil | $5.024B | 0.00 |
| BillionToOne (BLLN) | United States | $4.998B | 151.31 |
| Haemonetics (HAE) | United States | $4.932B | 21.64 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| ICU Medical (ICUI) | United States | $3.815B | 22.78 |
| Envista Holdings (NVST) | United States | $3.750B | 15.88 |
| AtriCure (ATRC) | United States | $2.955B | 252.61 |
| Neogen (NEOG) | United States | $2.835B | 50.00 |
| Curaleaf Holdings (CURLF) | United States | $2.445B | 0.00 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.265B | 0.00 |
| Trulieve Cannabis (TRLV) | United States | $2.132B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.130B | 10.17 |
| Perrigo (PRGO) | Ireland | $1.882B | 5.42 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.810B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.804B | 29.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.795B | 229.31 |
| Kestra Medical Technologies (KMTS) | United States | $1.455B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.426B | 15.21 |
| Phibro Animal Health (PAHC) | United States | $1.403B | 10.77 |
| Omeros (OMER) | United States | $1.294B | 6.55 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.065B | 0.00 |
| CeriBell (CBLL) | United States | $0.935B | 0.00 |
| InMode (INMD) | Israel | $0.825B | 11.48 |
| AdaptHealth (AHCO) | United States | $0.779B | 16.31 |
| VAREX IMAGING (VREX) | United States | $0.778B | 17.12 |
| Glass House Brands (GLAS) | United States | $0.748B | 0.00 |
| QuidelOrtho (QDEL) | United States | $0.728B | 7.87 |
| Valneva SE (VALN) | France | $0.622B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.553B | 0.00 |
| Brainsway (BWAY) | Israel | $0.547B | 30.93 |
| Tilray Brands (TLRY) | Canada | $0.543B | 0.00 |
| Cerus (CERS) | United States | $0.534B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.527B | 0.00 |
| Evolus (EOLS) | United States | $0.519B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.443B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.420B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| SNDL (SNDL) | Canada | $0.353B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.339B | 24.75 |
| Sanara MedTech (SMTI) | United States | $0.322B | 159.41 |
| TriSalus Life Sciences (TLSI) | United States | $0.314B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.279B | 0.00 |
| MacroGenics (MGNX) | United States | $0.264B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.251B | 13.35 |
| OraSure Technologies (OSUR) | United States | $0.246B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.235B | 22.55 |
| High Tide (HITI) | Canada | $0.230B | 51.60 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Exagen (XGN) | United States | $0.204B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.202B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.197B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.156B | 0.00 |
| Organigram Global (OGI) | Canada | $0.148B | 0.00 |
| Quanterix (QTRX) | United States | $0.145B | 0.00 |
| Apyx Medical (APYX) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| ImmuCell (ICCC) | United States | $0.090B | 124.38 |
| FitLife Brands (FTLF) | United States | $0.088B | 11.51 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Accendra Health (ACH) | United States | $0.068B | 3.87 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Hongchang (HCIL) | China | $0.055B | 0.00 |
| Biote (BTMD) | United States | $0.049B | 4.00 |
| Nephros (NEPH) | United States | $0.047B | 39.18 |
| Veru (VERU) | United States | $0.041B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.039B | 18.96 |
| United-Guardian (UG) | United States | $0.033B | 13.35 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.023B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.018B | 0.00 |
| Modular Medical (MODD) | United States | $0.018B | 0.00 |
| Bonk (BNKK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.001B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |